Concall Intelligence
Follow the Sept 2026 quarter results season by comparing what companies reported with what management said next. Search official call evidence, measurable guidance, changing outlook, operating risks, and prior commitments without treating commentary as a trading recommendation.
Management evidence
Generated 22 Oct, 8:57 am IST · click a summary to inspect source-linked evidence for this results quarter.
| Company | Call and sources | Reported result | Management outlook | Evidence-led conclusion | Review |
|---|---|---|---|---|---|
| TARIL Transformers And Rectifiers (India) Limited Industrials · Large | Sept 2026 21 Oct 2026 Transcript verified | Excellent 100/100 | Optimistic outlook No comparable prior call Guidance maintained | Transformers and Rectifiers (India) Limited delivered robust performance in Q2 FY27 with revenue up 60.8% YoY and PAT jumping 120.0% YoY, supported by improved capacity utilization and operating leverage. Unexecuted order book remains strong at INR7,237 crore, providing solid multi-year visibility despite lingering working capital pressures and elevated inventory levels. Evidence summary ready | |
| GALLANTT Gallantt Ispat Limited Metals · Large | Sept 2026 21 Oct 2026 Preliminary brief | Bad 0/100 | Optimistic outlook No comparable prior call Guidance maintained | Gallantt Ispat Limited reported stable top-line revenue of Rs 1,145.89 Cr for Q2 FY2027 (flat QoQ, up 13% YoY), but faced a sharp sequential contraction in profitability with PAT declining 51.1% QoQ to Rs 60.51 Cr and EBITDA margin narrowing to 9.64% due to higher raw material consumption and fixed costs. Evidence summary ready | |
| TECHM Tech Mahindra Limited IT · Large | Sep 2026 21 Oct 2026 Transcript verified | Excellent 80/100 | Optimistic outlook No comparable prior call No measurable guidance | Tech Mahindra delivered strong revenue and profit growth, highlighted AI and vertical wins, and expressed confidence in sustaining momentum into the December quarter. Evidence summary ready | |
| INDHOTEL The Indian Hotels Company Limited Consumer · Large | Sept 2026 21 Oct 2026 Preliminary brief | Average 52/100 | Optimistic outlook No comparable prior call Guidance raised | The Indian Hotels Company Limited reported strong financial results for Q2 FY27 with 21.7% YoY revenue growth and 19.4% YoY PAT growth, driven by robust domestic hospitality demand, scaling selective service brands, and asset management initiatives. Evidence summary ready | |
| INDIANB Indian Bank Financial Services · Mid | Sept 2026 21 Oct 2026 Transcript verified | Good 60/100 | Optimistic outlook No comparable prior call Guidance raised | Indian Bank reported a strong set of results for Q2 FY27 with net profit growing 14.71% YoY to Rs.3,462 crore (aided by NSE listing gains), healthy advances growth of 16.39%, and improving asset quality metrics with GNPA at 1.61%. Management has revised its deposit and advances growth guidance upwards for the full year while acknowledging potential headwinds from regulatory changes, potential HTM valuation shocks, and credit cost normalisation under ECL models. Evidence summary ready | |
| 360ONE 360 ONE WAM LIMITED Financial Services · Mid | Sept 2026 21 Oct 2026 Transcript verified | Bad 0/100 | Cautious outlook No comparable prior call No measurable guidance | Quarterly results showed modest revenue growth and a decline in profit, while management highlighted strong AUM growth, improved ARR retention, and long‑term profitability targets, but flagged margin pressure from higher costs and reliance on UBS flow execution. Evidence summary ready | |
| CCL CCL Products (India) Limited FMCG · Large | Sept 2026 21 Oct 2026 Transcript verified | Average 47/100 | Optimistic outlook No comparable prior call Guidance maintained | CCL delivered strong Q2 results with double‑digit volume growth and profit expansion, and management reaffirmed its FY27 guidance of ~15% volume and EBITDA growth, while noting coffee price volatility and capacity considerations. Evidence summary ready | |
| EMMVEE Emmvee Photovoltaic Power Limited Industrials · Large | Sep 2026 21 Oct 2026 Transcript verified | Good 67/100 | Optimistic outlook No comparable prior call Guidance maintained | Emmvee delivered strong Q2 FY27 results with double‑digit revenue and profit growth, maintained high margins, and indicated that its expansion projects are on schedule, but future finance costs will rise post‑commissioning. Evidence summary ready | |
| ARSSBL Anand Rathi Share and Stock Brokers Limited Financial Services · Small | Sept 2026 21 Oct 2026 Transcript verified | Excellent 77/100 | Optimistic outlook No comparable prior call Guidance maintained | Anand Rathi Share and Stock Brokers Limited delivered a robust financial performance in Q2 FY27, reporting strong year-on-year growth in revenue and PAT supported by expansion in the Margin Trading Facility (MTF) and distribution businesses, despite a turbulent secondary market. Evidence summary ready | |
| DBCORP D.B.Corp Limited Media · Small | Sept 2026 21 Oct 2026 Transcript verified | Bad 0/100 | Optimistic outlook No comparable prior call Guidance maintained | D.B. Corp reported a decline in Q2 FY27 revenue and PAT due to the festive season (Navaratra) shifting into Q3 and temporary headwinds such as panchayat election codes of conduct, though underlying advertising and EBITDA registered positive single-digit growth on a like-to-like basis. Evidence summary ready | |
| E2E E2E Networks Limited IT · Small | Sept 2026 21 Oct 2026 Transcript verified | Good 55/100 | Optimistic outlook No comparable prior call No measurable guidance | E2E Networks delivered robust financial performance in Q2 FY27 with triple-digit YoY revenue growth and margin expansion, supported by Blackwell GPU deployment and improved utilization. Management maintains a disciplined approach to capex and avoids speculative guidance. Evidence summary ready | |
| ICICIPRULI ICICI Prudential Life Insurance Company Limited Financial Services · Large | Sep 2026 21 Oct 2026 Transcript verified | Good 65/100 | Optimistic outlook No comparable prior call No measurable guidance | ICICI Life delivered solid revenue and profit growth despite macro volatility, with strong VNB expansion and margin stability, while emphasizing continued investment in agency distribution and upcoming regulatory reforms. Evidence summary ready | |
| SGFIN SG Finserve Limited Financial Services · Small | Sep 2026 21 Oct 2026 Transcript verified | Excellent 80/100 | Cautious outlook No comparable prior call New guidance | SG Finserve delivered strong Q2 FY27 results with record PAT and loan book growth, but management plans to increase leverage to 4x and targets 30‑35% AUM growth YoY, introducing execution and capital‑raising considerations. Evidence summary ready | |
| ANGELONE Angel One Limited Financial Services · Small | Sept 2026 21 Oct 2026 Transcript verified | Excellent 90/100 | Optimistic outlook No comparable prior call Guidance maintained | Angel One delivered resilient Q2 FY27 results with consolidated revenue of 14.3 billion rupees and PAT of 3.35 billion rupees despite subdued capital market volumes. Operating margins expanded significantly year-over-year, supported by operating leverage and a diversified revenue mix. Evidence summary ready | |
| BAJAJCON Bajaj Consumer Care Limited Consumer · Small | Sept 2026 21 Oct 2026 Transcript verified | Excellent 90/100 | Optimistic outlook No comparable prior call No measurable guidance | Bajaj Consumer Care delivered a resilient performance in Q2 FY27 amid raw material volatility, reporting double-digit unit volume growth in its core Almond Drops franchise and maintaining strong EBITDA and PAT margins through fixed cost efficiencies. Evidence summary ready | |
| TIPSMUSIC Tips Music Limited Media · Micro | Sept 2026 21 Oct 2026 Transcript verified | Good 62/100 | Optimistic outlook No comparable prior call Guidance raised | Tips Music delivered strong top‑line and profit growth in Q2 FY27, driven by new releases and catalog performance across digital and non‑digital platforms. Management upgraded FY27 growth guidance but highlighted a front‑loaded content spend, ongoing YouTube Shorts negotiations and a smaller‑film focus for H2. Evidence summary ready | |
| HDBFS HDB Financial Services Limited Financial Services · Large | Sept 2026 20 Oct 2026 Transcript verified | Good 55/100 | Optimistic outlook No comparable prior call No measurable guidance | HDB Financial Services delivered strong top‑line and profit growth in Q2 FY27, driven by robust disbursements across enterprise and consumer segments, improved asset quality and margins, and continued capital strength. Management is optimistic about H2, citing festive demand and capacity to scale, but flags monsoon‑related inflation, seasonal asset‑quality pressures and regulatory fee uncertainties as risks. Evidence summary ready | |
| LOTUSDEV Sri Lotus Developers and Realty Limited Real Estate · Micro | Sept 2026 19 Oct 2026 Transcript verified | Excellent 100/100 | Optimistic outlook No comparable prior call New guidance | Sri Lotus delivered strong revenue and profit growth in Q2 FY27, with robust pre‑sales and expanding margins, while management signals confidence in H2 launches and FY27 targets, albeit with execution and pricing risks. Evidence summary ready | |
| IXIGO Le Travenues Technology Limited Consumer · Micro | Sep 2026 19 Oct 2026 Preliminary brief | Average 35/100 | Optimistic outlook No comparable prior call No measurable guidance | Le Travenues Technology Limited (IXIGO) reported resilient Q2 FY27 performance with GTV up 22% YoY and revenue from operations up 13% YoY to Rs 321 Crores, supported by strong growth in Flight and Bus segments and the new Hotel line. PAT reached an all-time high aided by a partial stake sale in Freshbus, while management continues to invest in hotels and AI capabilities. Evidence summary ready | |
| SEJALLTD Sejal Glass Limited Industrials · Small | Sep 2026 19 Oct 2026 Preliminary brief | Excellent 100/100 | Optimistic outlook No comparable prior call Guidance maintained | Sejal Glass reported strong year-on-year revenue and profit growth for Q2 FY27, driven by higher capacity utilisation, integration of acquired Glasstech plants, and robust performance from its UAE subsidiary. Management remains optimistic about achieving 25% to 40% revenue growth in FY27, supported by scaling operations and new specialty product launches. Evidence summary ready | |
| UNIONBANK Union Bank of India Financial Services · Large | Sept 2026 19 Oct 2026 Preliminary brief | Good 70/100 | Optimistic outlook No comparable prior call No measurable guidance | Union Bank of India delivered solid financial performance for Q2 FY2027 with strong growth in Net Interest Income, improved asset quality metrics including lower GNPA and NNPA ratios, and robust capital adequacy, alongside ongoing investments in digital initiatives and centralized surveillance systems. Evidence summary ready | |
| HERITGFOOD Heritage Foods Limited FMCG · Micro | Sept 2026 19 Oct 2026 Transcript verified | Bad 0/100 | Cautious outlook No comparable prior call No measurable guidance | Heritage Foods posted solid top-line growth but margin pressure from higher milk procurement costs led to a 39.5% YoY decline in PAT, while EBITDA margin improved sequentially. Evidence summary ready | |
| YESBANK Yes Bank Limited Financial Services · Mid | Sep 2026 19 Oct 2026 Preliminary brief | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Yes Bank reported a Q2FY27 net profit of INR 1,080 crores, up 65% year-on-year, driven by healthy core operating income and steady asset quality, though the Supreme Court judgment on AT-1 bonds remains unrecognised pending assessment. Evidence summary ready | |
| TATAELXSI Tata Elxsi Limited IT · Mid | Sept 2026 19 Oct 2026 Transcript verified | Average 45/100 | Optimistic outlook No comparable prior call No measurable guidance | Tata Elxsi reported Q2 FY27 operating revenue of INR 1055.7 crores (up 2.3% QoQ in constant currency) and an EBITDA margin of 21.9%, absorbing annual wage hikes through operational leverage and realization of one-offs. While US and India markets performed well, Europe remains soft and sluggish, particularly in automotive. Management expects an upward margin trajectory and better second-half performance compared to the first half. Evidence summary ready | |
| ICICIGI ICICI Lombard General Insurance Company Limited Financial Services · Mid | Sept 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | ICICI Lombard General Insurance Company Limited reported robust H1 FY2027 performance, outpacing industry growth in segments like Retail Health and Commercial lines while maintaining strict underwriting discipline, though overall PBT and PAT dipped slightly and industry-wide Motor combined ratios remained heavily stressed. Evidence summary ready | |
| TATATECH Tata Technologies Limited IT · Small | Sep 2026 19 Oct 2026 Transcript verified | Average 32/100 | Optimistic outlook No comparable prior call No measurable guidance | Tata Technologies delivered solid revenue growth and maintained operating margin despite salary headwinds, but sequential PAT declined and technology solutions revenue fell due to accounting changes. Evidence summary ready | |
| KARURVYSYA Karur Vysya Bank Limited Financial Services · Small | Sep 2026 19 Oct 2026 Transcript verified | Excellent 75/100 | Optimistic outlook No comparable prior call Guidance maintained | Karur Vysya Bank delivered strong revenue and profit growth in Q2 FY26-27, with business expansion and robust CASA inflows, while maintaining NIM above guidance; management signals cautious but optimistic outlook for FY26-27 growth of 18-20% and highlights competitive pressure on margins. Evidence summary ready | |
| IOLCP IOL Chemicals and Pharmaceuticals Limited Industrials · Small | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | IOL Chemicals and Pharmaceuticals Limited reported its business update call focusing on three strategic growth initiatives totalling approximately INR500 crores, including Ibuprofen capacity expansion, entry into the CDMO formulations segment, and a specialty chemical tolling arrangement. Management highlighted disciplined internal accrual funding and long-term customer relationships, while noting that input prices have stabilized and some product prices have softened from pe Evidence summary ready | |
| TEMPSENS Tempsens Instruments (India) Limited Industrials · Micro | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Tempsens Instruments (India) Limited reported a strong Q1 FY27 with revenue growing 33% YoY to INR118 crores and export revenues rising 78.3%, while EBITDA margins moderated by 330 bps to 22% due to employee cost investments for future growth and timing of execution. Evidence summary ready | |
| METROPOLIS Metropolis Healthcare Limited Pharma · Micro | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Metropolis Healthcare reported robust strategic positioning during its Investor and Analyst Meet, highlighting strong volume-led growth across B2C and B2B channels, expansion in tier-2/tier-3 towns, and margin expansion levers driven by specialty testing, genomics, and network productivity. Evidence summary ready | |
| POLICYBZR PB Fintech Limited Financial Services · Mid | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Cautious outlook No comparable prior call No measurable guidance | PB Fintech held an analyst and investor call addressing the draft regulatory proposals by the insurance regulator concerning commissions and distribution economics. Management stated that while life insurance NPV remains largely unaffected, general insurance (particularly retail health) faces a serious top-line compression of one-third to 40%. The company plans to absorb details, evaluate cost rationalization levers, and explore manufacturing and service monetization options. Evidence summary ready | |
| NOVARTIND Novartis India Limited Pharma · Small | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Novartis India Limited is undergoing a complete commercial reset following its acquisition by ChrysCapital. The management aims to transition the company from a flattish revenue trajectory to a high-growth platform by building an internal field force of ~900 representatives, expanding distribution to 25 C&Fs and 4,000-5,000 distributors, executing strategic M&As (such as Minipress XL and ophthalmology in-licensing), and focusing on six core therapy areas. Evidence summary ready | |
| INDOBORAX Indo Borax & Chemicals Limited Industrials · Small | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Indo Borax reported strong Q1 FY27 results with 31% operating revenue growth and a 59% jump in net profit, supported by robust execution and improved realizations. Management remains focused on operational efficiency, capacity utilization, and executing the acquisition of a majority stake in Kronox Lab Sciences. Evidence summary ready | |
| HTEL Hy-Tech Engineers Limited Industrials · Micro | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Hy-Tech Engineers reported stable revenue of INR430 million in Q1 FY27, up 13% YoY, while margins saw mild pressure due to raw material price inflation before compensated revisions take effect. Management remains confident in steady long-term growth driven by capacity expansion from IPO proceeds, export penetration, and import substitution. Evidence summary ready | |
| INDIGOPNTS Indigo Paints Limited Consumer · Micro | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Indigo Paints delivered a strong Q1 FY27 with 18.7% standalone revenue growth and a 42% jump in EBITDA, outperforming the broader paint sector despite initial raw material supply disruptions triggered by the Iran conflict. Evidence summary ready | |
| SHANKESH Shankesh Jewellers Limited Consumer · Micro | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Shankesh Jewellers Limited reported its maiden Q1 FY27 earnings post listing, highlighting strong top-line and margin expansion driven by product mix and festive demand, though the steep margin trajectory and heavy reliance on short-term working capital require close monitoring. Evidence summary ready | |
| XTGLOBAL Xtglobal Infotech Limited IT · Small | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Xtglobal Infotech reported steady operating performance for Q1 FY27 with modest revenue growth offset by a shift from onsite to offshore delivery, leading to margin expansion. Evidence summary ready | |
| FORTIS Fortis Healthcare Limited Pharma · Mid | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Management addressed investor queries following the Delhi High Court order directing a forensic audit related to historical promoter share dissipation and IHH's acquisition, maintaining that operations remain insulated and strategic growth plans are unaffected. Evidence summary ready | |
| HORIZONIND Horizon Industrial Parks Limited Real Estate · Small | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Horizon Industrial Parks Limited reported a strong Q1 FY27 operating performance with 23% YoY revenue growth to INR200 crores and an EBITDA margin of 80%, supported by successful IPO primary capital raising of INR4,250 crores used for deleveraging. Evidence summary ready | |
| GAJA Gaja Alternative Asset Management Limited Financial Services · Micro | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Gaja Alternative Asset Management Limited reported a steady performance for Q1 FY27 with total income growing 26% YoY to INR51.8 crores and PAT growing 35% YoY to INR27.2 crores, supported by strong institutional interest following its successful IPO. Evidence summary ready | |
| SKYWAYS Skyways Air Services Limited Services · Micro | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Skyways Air Services Limited reported a strong first earnings call for Q1 FY27, showcasing stellar revenue and operating EBITDA growth driven by robust air and ocean cargo volumes, alongside successful navigation of geopolitical crises like the West Asia conflict. However, yield improvements are largely tied to dynamic fuel index increases which act as a complete pass-through, and certain legal overhangs remain sub judice. Evidence summary ready | |
| ASTERDM Aster DM Healthcare Limited Pharma · Small | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | The successful merger and strong proforma FY2026 results, coupled with clear strategic priorities for integration and network expansion, suggest the company is on track to leverage scale and clinical depth. Management's focus on capital efficiency and margin improvement supports the long-term value creation thesis. Evidence summary ready | |
| HAPPSTMNDS Happiest Minds Technologies Limited IT · Micro | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Happiest Minds Technologies announced a proposed combination with ITC Infotech involving a promoter stake sale by Mr. Soota and a subsequent scheme of amalgamation of Happiest Minds into ITC Infotech, aiming to accelerate the $1 billion revenue target to FY28. Evidence summary ready | |
| ESDS ESDS Software Solution Limited IT · Small | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | ESDS Software Solution reported steady Q1 FY27 results with revenue of INR 133.66 crores up 7.28% YoY and PAT of INR 29.28 crores up 14% YoY, while experiencing a sequential revenue dip due to prior quarter design services. Management highlighted strategic progress in AI cloud infrastructure and significant international GPU demand backed by substantial customer advances, though execution and delivery schedules remain sensitive to global hardware supply constraints. Evidence summary ready | |
| UJJIVANSFB Ujjivan Small Finance Bank Limited Financial Services · Micro | Sep 2026 19 Oct 2026 Transcript verified | Excellent 85/100 | Optimistic outlook No comparable prior call Guidance maintained | Ujjivan Small Finance Bank announced the early retirement of its MD & CEO due to health reasons and appointed Ms. Carol Furtado as Interim MD & CEO. Management reassured stakeholders of continuity in strategy, strong governance, and commitment to FY27 guidance, emphasizing that growth plans and capital adequacy remain unaffected by the leadership transition or potential delays in capital raising. The search for a permanent MD & CEO has been expedited. Evidence summary ready | |
| IDEA Vodafone Idea Limited Telecom · Mid | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Vodafone Idea delivered a positive Q1 FY27 with revenue up 6.0% YoY to Rs. 11,689 Crore and Cash EBITDA up 13.5% YoY to Rs. 2,475 Crore, alongside the company's first quarter of positive net subscriber additions since its merger. Management maintains its 3-year Rs. 45,000 Crore capex plan and 3x cash EBITDA ambitions, backed by Rs. 6,400 Crore of initial funding mobilization, though supply chain headwinds slightly dented quarterly capex deployment. Evidence summary ready | |
| SRGHFL SRG Housing Finance Limited Financial Services · Small | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Cautious outlook No comparable prior call No measurable guidance | SRG Housing Finance held an emergency business update call to refute a damaging newspaper report regarding alleged promoter siphoning and fictitious accounts, confirming that an ongoing annual NHB supervisory audit triggered a Red Flag Account (RFA) classification which management expects to be removed shortly. Evidence summary ready | |
| RACLGEAR RACL Geartech Limited IT · Small | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | RACL Geartech reported robust Q1 FY27 financial performance with consolidated revenue growing 22% YoY to Rs. 132.6 crores and EBITDA expanding 18% YoY to Rs. 32.2 crores, backed by strong execution in domestic markets and resilience in European exports, particularly KTM. Evidence summary ready | |
| URBANCO Urban Company Limited Consumer · Small | Sep 2026 17 Oct 2026 Transcript verified | Bad 22/100 | Optimistic outlook No comparable prior call Guidance maintained | Urban Company reported strong growth across its core businesses, with consolidated NTV up 39.1% YoY and revenue up 41.4% YoY. The core businesses (India Consumer Services, International, Native) are showing significant operating leverage and margin expansion, leading to a positive adjusted EBITDA of ₹30 crores excluding InstaHelp. However, consolidated results reflect a substantial ₹174 crore investment in InstaHelp, which remains a strategic focus for long-term market leader Evidence summary ready | |
| CANBK Canara Bank Financial Services · Large | Sept 2026 17 Oct 2026 Transcript verified | Average 50/100 | Optimistic outlook No comparable prior call Guidance maintained | Canara Bank delivered a strong Q2 FY27, significantly surpassing most of its annual guidance targets across business growth, advances, deposits, asset quality, and profitability. While treasury operations faced headwinds, robust Net Interest Income growth compensated for the losses. Management remains optimistic about sustaining performance and managing the anticipated one-time ECL provisioning impact over the next few years. Evidence summary ready |